IVF News and Research RSS Feed - IVF News and Research

RMANJ releases new fertility checklist for early diagnosis and treatment options

With over seven million men and women in the United States impacted by infertility, information about early diagnosis and various infertility treatment options like in vitro fertilization (IVF), preimplantation genetic diagnosis (PGD), and comprehensive chromosome screening (CCS) can offer help to many patients looking to overcome infertility. [More]
Vivere-Winter Park recognizes 25th Annual National Infertility Awareness Week

Vivere-Winter Park recognizes 25th Annual National Infertility Awareness Week

Infertility is a disease affecting more than 7 million people across the U.S., according to the National Survey of Family Growth. That number represents 12 percent of women of childbearing age or one in eight couples. [More]

Nora Therapeutics closes $18M Series B financing to expand drug development

Nora Therapeutics, a biotechnology company focused on developing therapeutics to address unmet needs in reproductive medicine, today announced the closing of an $18 million Series B financing. [More]

Financial pressures lead patients, doctors to choose fertility treatments that raise risk of premature birth

While it is well known that fertility treatments are the leading cause of increases in multiple gestations and that multiples are at elevated risk of premature birth, these results are not inevitable, concludes an article in Fertility and Sterility. [More]

IVF prevents multiple births in patients undergoing fertility treatments

While fertility treatments have helped many people become parents, they commonly result in multiple births, increasing the risk of prematurity, and leading to lifelong complications. [More]

Auxogyn signs exclusive license agreement with Merck Serono for Eeva Test

Auxogyn, Inc., a company dedicated to advancing women's reproductive health, today announced an exclusive license agreement with Merck Serono, the biopharmaceutical division of Merck KGaA, Darmstadt, Germany which operates as EMD Serono in the United States and Canada, for Auxogyn's proprietary Early Embryo Viability Assessment (Eeva) Test. [More]
Research shows that use of fertility drugs does not increase breast cancer risk

Research shows that use of fertility drugs does not increase breast cancer risk

Women who took clomiphene citrate (brand name Clomid) or gonadotropins as a part of fertility treatment did not experience an increased risk for breast cancer over 30 years of follow-up, compared with women who were not treated with these medications, according to a study published in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research. [More]

Study provides better understanding of why chromosome errors are high in women's eggs

A new study from the University of Southampton has provided scientists with a better understanding of why chromosome errors are high in women's eggs. [More]

New study assesses effectiveness of two surgical treatments for ectopic pregnancy

A new study from Wake Forest Baptist Medical Center looked at pregnancy outcomes in regards to the two surgical treatments for ectopic pregnancy -- salpingectomy, in which the affected fallopian tube is removed, or salpingotomy, in which the tube is preserved. [More]

New study shows male hormones play important role; may enhance IVF therapy in women

Several fertility clinics across the country are beginning to administer testosterone, either through a patch or a gel on the skin, to increase the number of eggs produced by certain women undergoing in vitro fertilization (IVF). [More]

Forecast report on Global IVF market

Reportbuyer.com just published a new market research report: Global In Vitro Fertilization Market 2012-2016 [More]

New video tracking system could help select most viable sperm

To improve their chances of success, in vitro fertilization (IVF) clinics need to assess the viability of the sperm they use. Now doctors may soon have a new technique to help them sort the good sperm cells from the less viable ones: a tracking system, developed by a team of researchers from four European institutions, that takes 3-D movies of living sperm. [More]
Rubicon Genomics introduces PicoPLEX DNA-seq Kits for use with Illumina NGS platforms

Rubicon Genomics introduces PicoPLEX DNA-seq Kits for use with Illumina NGS platforms

Rubicon Genomics, Inc. today announced the launch of its PicoPLEX DNA-seq Kits for use with Illumina next-generation sequencing (NGS) platforms. PicoPLEX's outstanding robustness and reproducibility have made it the worldwide standard for single-cell DNA amplification for microarray and PCR-based pre-implantation genetic screening and diagnosis. PicoPLEX DNA-seq now enables researchers and clinicians to access PicoPLEX technology for analyses conducted on Illumina NGS systems. [More]
Researchers discover how 'entrance exam' set by womb determines if implantation of an embryo is successful

Researchers discover how 'entrance exam' set by womb determines if implantation of an embryo is successful

Researchers have discovered how an 'entrance exam' set by the womb determines if the implantation of an embryo is successful; potentially a milestone for advances in pregnancy treatments. [More]
Women who have child after experiencing fertility problems are more likely to remain with partner

Women who have child after experiencing fertility problems are more likely to remain with partner

New reseach reveals that women who have a child after experiencing fertility problems are more likely to remain with their partner following infertility evaluations. [More]
New method allows for large-scale generation of human embryonic stem cells

New method allows for large-scale generation of human embryonic stem cells

A new method allows for large-scale generation of human embryonic stem cells of high clinical quality. It also allows for production of such cells without destroying any human embryos. [More]

Risk of serious complications higher for babies conceived by assisted reproductive therapies

A University of Adelaide study has shown that the risk of serious complications such as stillbirth, preterm birth, low birth weight and neonatal death is around twice as high for babies conceived by assisted reproductive therapies compared with naturally conceived babies. [More]

Researchers assess direct out-of-pocket costs for couples undergoing fertility treatment

From drug therapy to IVF, out-of pocket costs can range from $900 to $19,000 per treatment cycle, report researchers in The Journal of Urology [More]

ARMI reveals new insights into how cells organize and form an early mammalian embryo

In research published today in Nature Cell Biology, scientists from the EMBL Australia research team based at Monash University's Australian Regenerative Medicine Institute (ARMI) have revealed new insights into how cells organise and form an early mammalian embryo. [More]

OvaScience reports net loss of $6.9 million in Q3 2013

OvaScienceSM, a life sciences company focused on the discovery, development and commercialization of new treatments for infertility, today reported financial results for the quarter ended September 30, 2013, as well as recent highlights. [More]